Clinical Trial Update: Efficacy and Toxicity of Blinatumomab in the French ATU for Adult BCP-ALL R/R, or With MRD+ (FRENCH-CYTO)

View source ↗

Summary

This completed French ATU study assessed the efficacy and safety of blinatumomab in adults with B-cell precursor acute lymphoblastic leukemia that is relapsed o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Blinatumomab (Blincyto) (blinatumomab)

Snippet

Sponsor: Group for Research in Adult Acute Lymphoblastic Leukemia | Conditions: Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia With Failed Remission | Status: COMPLETED